Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Jesse NeriSVP and CFO | Rockwell MedicalRMTI | Open-market sale10b5-1 plan | 01/02 | 01/05 | 886 sh | $0.84 | $744.24 | −0.7% |
Rockwell MedicalRMTI | Open-market sale10b5-1 plan | 01/02 | 01/05 | 2,868 sh | $0.84 | $2,409.12 | −2.1% | |
John G. CooperDirector | Rockwell MedicalRMTI | Open-market sale | 25/11/18 | 25/11/18 | 5,079 sh | $0.87 | $4,418.73 | −3.5% |
Heather HunterSVP, COO | Rockwell MedicalRMTI | Open-market sale10b5-1 plan | 25/10/01 | 25/10/08 | 2,868 sh | $1.19 | $3,412.92 | −2.1% |
Strobeck MarkPresident and CEO | Rockwell MedicalRMTI | Open-market sale10b5-1 plan | 25/10/01 | 25/10/01 | 6,926 sh | $1.19 | $8,241.94 | −2.1% |
Jesse NeriSVP and CFO | Rockwell MedicalRMTI | Open-market sale10b5-1 plan | 25/10/01 | 25/10/01 | 886 sh | $1.19 | $1,054.34 | −0.7% |
Chole TimothySVP and CCO | Rockwell MedicalRMTI | Open-market sale10b5-1 plan | 25/10/01 | 25/10/01 | 2,868 sh | $1.19 | $3,412.92 | −2.2% |
Strobeck MarkPresident and CEO | Rockwell MedicalRMTI | Open-market sale10b5-1 plan · Amendment | 25/07/01 | 25/07/03 | 6,926 sh | $0.82 | $5,679.32 | −2.0% |
Jesse NeriSVP and CFO | Rockwell MedicalRMTI | Open-market sale10b5-1 plan · Amendment | 25/07/01 | 25/07/03 | 886 sh | $0.82 | $726.52 | −0.7% |
Chole TimothySVP and CCO | Rockwell MedicalRMTI | Open-market sale10b5-1 plan · Amendment | 25/07/01 | 25/07/03 | 2,868 sh | $0.82 | $2,351.76 | −2.2% |
Strobeck MarkPresident and CEO | Rockwell MedicalRMTI | Open-market sale | 25/07/01 | 25/07/02 | 6,926 sh | $0.82 | $5,679.32 | −2.0% |
Jesse NeriSVP and CFO | Rockwell MedicalRMTI | Open-market sale | 25/07/01 | 25/07/02 | 886 sh | $0.82 | $726.52 | −0.7% |
Chole TimothySVP and CCO | Rockwell MedicalRMTI | Open-market sale | 25/07/01 | 25/07/02 | 2,868 sh | $0.82 | $2,351.76 | −2.2% |
Rockwell MedicalRMTI | Open-market buy | 25/04/10–25/04/11 | 25/04/15 | 87,500 sh30 trades | $1.07avg. | $94,055 | +2.5% | |
Strobeck MarkPresident and CEO | Rockwell MedicalRMTI | Open-market sale10b5-1 plan | 25/04/01 | 25/04/02 | 6,926 sh | $1.08 | $7,480.08 | −5.3% |
Jesse NeriSVP, Finance and CFO | Rockwell MedicalRMTI | Open-market sale10b5-1 plan | 25/04/01 | 25/04/02 | 886 sh | $1.10 | $974.6 | −2.9% |
Chole TimothySVP, Chief Commercial Officer | Rockwell MedicalRMTI | Open-market sale10b5-1 plan | 25/04/01 | 25/04/02 | 2,868 sh | $1.08 | $3,097.44 | −5.9% |
Strobeck MarkPresident and CEO | Rockwell MedicalRMTI | Open-market sale10b5-1 plan | 25/01/02 | 25/01/06 | 2,163 sh | $2.06 | $4,455.78 | −1.5% |
Chole TimothySVP, Chief Commercial Officer | Rockwell MedicalRMTI | Open-market sale10b5-1 plan | 25/01/02 | 25/01/06 | 1,001 sh | $2.05 | $2,052.05 | −1.8% |
Rockwell MedicalRMTI | Open-market sale | 24/11/15 | 24/11/19 | 29,991 sh2 trades | $2.35avg. | $70,379.12 | No record |